MicroStrategy: Canaccord Initiates With $920 Price Target
On Friday, Canaccord Genuity initiated coverage on MicroStrategy (NASDAQ: MSTR) with a $920 price target and buy rating. Joseph Vafi,
The Latest
Full Analysis
Tensegrity: How the Archegos Tower was Built
Last Week in Bill Hwang saw the head of investment banking and the Chief Risk Manager getting the axe at
Education
Arizona: A Resurgence of Gold Exploration
Arizona has a history of mining extending back to the 18th century. The Spanish, who along with Mexico controlled much
Macro
Investment in Building Construction Hits Another Record High in February
Investment in Canada’s building construction topped a record high in February for the second month in a row, amid continued
Cannabis
Trulieve Closes $287.5 Million Financing With US-Based Investors
Trulieve Cannabis (CSE: TRUL) has closed its previously announced marketed public offering of shares, the first such offering available in
Commentary
Clover Health Versus Hindenburg Research
SPAC product Clover Health (NASDAQ: CLOV) has found itself in a long winded back-and-forth with a renegade short seller on
Resources
AUX Resources To Be Acquired By Scottie Resources
Aux Resource Corp (TSXV: AUX) is set to be acquired by that of Scottie Resource Corp (TSXV: SCOT). The two
Technology
MicroStrategy: Canaccord Initiates With $920 Price Target
On Friday, Canaccord Genuity initiated coverage on MicroStrategy (NASDAQ: MSTR) with a $920 price target and buy rating. Joseph Vafi,
